| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
92,706 |
85,403 |
$35.26M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
71,695 |
64,263 |
$29.75M |
| 0450 |
Emergency room services |
65,607 |
58,054 |
$13.80M |
| 0762 |
|
4,932 |
2,015 |
$4.98M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,870 |
5,548 |
$3.05M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,359 |
8,985 |
$1.37M |
| 70450 |
Computed tomography, head or brain; without contrast material |
14,095 |
13,668 |
$1.15M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
28,776 |
25,196 |
$1.13M |
| Z7502 |
|
28,714 |
28,169 |
$1.03M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
890 |
869 |
$1.02M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
23,506 |
21,696 |
$765K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
15,212 |
14,986 |
$755K |
| 80053 |
Comprehensive metabolic panel |
118,781 |
109,138 |
$748K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
52,155 |
48,476 |
$661K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
138,458 |
123,084 |
$644K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
40,704 |
37,018 |
$629K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
8,184 |
7,996 |
$536K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
21,762 |
18,762 |
$509K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,903 |
11,445 |
$489K |
| G0378 |
Hospital observation service, per hour |
665 |
466 |
$418K |
| 0360 |
|
2,081 |
1,892 |
$402K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,510 |
7,167 |
$373K |
| 71046 |
Radiologic examination, chest; 2 views |
25,777 |
24,845 |
$367K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,914 |
2,877 |
$320K |
| J3490 |
Unclassified drugs |
56,582 |
29,758 |
$310K |
| 0760 |
|
4,038 |
3,583 |
$279K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,910 |
5,795 |
$253K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,220 |
14,282 |
$246K |
| 84484 |
|
39,236 |
35,319 |
$244K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,923 |
4,613 |
$238K |
| 0270 |
|
23,882 |
13,302 |
$219K |
| 71045 |
Radiologic examination, chest; single view |
29,367 |
28,175 |
$212K |
| 83690 |
|
48,012 |
44,682 |
$208K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,416 |
4,279 |
$198K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
30,509 |
26,723 |
$176K |
| 20610 |
|
5,344 |
4,486 |
$169K |
| 0761 |
|
2,373 |
1,955 |
$166K |
| Z9725 |
|
3,512 |
3,467 |
$151K |
| 93971 |
|
2,355 |
2,313 |
$148K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
8,657 |
6,910 |
$132K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28,635 |
26,601 |
$131K |
| 81001 |
|
54,156 |
50,939 |
$131K |
| 87040 |
|
10,382 |
9,225 |
$130K |
| 83880 |
|
9,194 |
8,730 |
$126K |
| 99070 |
|
164,661 |
78,308 |
$118K |
| Z7610 |
|
16,519 |
9,525 |
$114K |
| 83605 |
|
13,224 |
12,126 |
$112K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
11,213 |
10,826 |
$109K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
518 |
493 |
$109K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
545 |
517 |
$102K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
226 |
222 |
$101K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,581 |
2,530 |
$99K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,432 |
2,393 |
$97K |
| 73564 |
|
3,290 |
2,997 |
$95K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,094 |
3,032 |
$93K |
| 81025 |
|
25,394 |
24,212 |
$93K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
1,577 |
1,486 |
$93K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,768 |
4,086 |
$92K |
| 76801 |
|
3,192 |
2,892 |
$90K |
| 90715 |
|
2,106 |
2,085 |
$88K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
15,042 |
12,671 |
$88K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,415 |
1,396 |
$87K |
| 73030 |
|
4,156 |
3,981 |
$85K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16,144 |
15,463 |
$83K |
| 84703 |
|
9,128 |
8,711 |
$81K |
| 70486 |
|
882 |
874 |
$81K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
38 |
38 |
$76K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
18,890 |
16,580 |
$73K |
| 72100 |
|
3,705 |
3,623 |
$72K |
| 73130 |
|
2,926 |
2,818 |
$67K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,658 |
1,620 |
$66K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,721 |
8,736 |
$63K |
| 73610 |
|
3,052 |
2,936 |
$63K |
| 81003 |
|
29,340 |
28,143 |
$60K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12,341 |
10,932 |
$60K |
| 73562 |
|
3,814 |
3,693 |
$60K |
| 0160 |
|
399 |
126 |
$58K |
| 73110 |
|
2,582 |
2,337 |
$58K |
| 93975 |
|
1,010 |
996 |
$56K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,286 |
2,041 |
$56K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12,251 |
11,394 |
$56K |
| 0710 |
|
2,153 |
1,967 |
$54K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
476 |
474 |
$52K |
| 84702 |
|
4,152 |
3,523 |
$50K |
| 96376 |
|
1,076 |
762 |
$50K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
397 |
393 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,503 |
7,306 |
$49K |
| 73630 |
|
2,822 |
2,767 |
$49K |
| 85730 |
|
11,168 |
10,744 |
$48K |
| 72131 |
|
632 |
631 |
$44K |
| 85610 |
|
13,349 |
12,673 |
$41K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
507 |
463 |
$41K |
| 73502 |
|
1,758 |
1,670 |
$41K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,442 |
3,353 |
$38K |
| 36415 |
Collection of venous blood by venipuncture |
21,315 |
18,415 |
$37K |
| 76830 |
Ultrasound, transvaginal |
1,084 |
1,075 |
$37K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,328 |
3,241 |
$36K |
| 82962 |
|
11,587 |
8,458 |
$35K |
| 87081 |
|
7,244 |
7,041 |
$35K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
881 |
849 |
$33K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,689 |
6,162 |
$32K |
| 72040 |
|
1,641 |
1,591 |
$31K |
| 29848 |
|
29 |
29 |
$29K |
| 93970 |
|
556 |
552 |
$28K |
| 83735 |
|
7,782 |
5,502 |
$28K |
| 87507 |
|
241 |
237 |
$28K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
321 |
306 |
$27K |
| 73080 |
|
1,193 |
1,168 |
$27K |
| 99199 |
Unlisted special service, procedure or report |
536 |
478 |
$26K |
| 87186 |
|
3,265 |
3,183 |
$26K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,118 |
1,019 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,625 |
2,580 |
$25K |
| 71020 |
|
468 |
279 |
$24K |
| 85379 |
|
2,753 |
2,685 |
$24K |
| 73590 |
|
1,339 |
1,296 |
$23K |
| 84145 |
|
3,552 |
3,436 |
$23K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
497 |
496 |
$23K |
| 87631 |
|
676 |
647 |
$23K |
| 87077 |
|
4,571 |
4,455 |
$22K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,625 |
3,482 |
$21K |
| 73090 |
|
1,230 |
1,163 |
$21K |
| J1815 |
Injection, insulin, per 5 units |
2,363 |
1,404 |
$21K |
| 76870 |
|
770 |
754 |
$21K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,103 |
3,728 |
$20K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,821 |
2,147 |
$19K |
| 73140 |
|
1,223 |
1,101 |
$18K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
877 |
792 |
$18K |
| 85027 |
|
3,938 |
3,777 |
$18K |
| 96367 |
|
1,233 |
1,130 |
$17K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,840 |
3,453 |
$17K |
| 71101 |
|
737 |
733 |
$17K |
| 82803 |
|
2,420 |
2,323 |
$17K |
| 72110 |
|
442 |
404 |
$17K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
140 |
138 |
$16K |
| 86901 |
|
5,241 |
5,043 |
$16K |
| 57288 |
|
12 |
12 |
$15K |
| 59025 |
Fetal non-stress test |
1,404 |
1,142 |
$15K |
| 82550 |
|
2,477 |
2,333 |
$15K |
| 80305 |
|
650 |
587 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,690 |
1,564 |
$14K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
640 |
637 |
$14K |
| 99153 |
Mod sedat endo service >5yrs |
1,266 |
1,211 |
$14K |
| 70496 |
|
443 |
440 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
2,111 |
1,924 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,032 |
759 |
$13K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,842 |
2,575 |
$13K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,553 |
2,326 |
$12K |
| 71250 |
|
282 |
279 |
$12K |
| 0510 |
|
418 |
370 |
$12K |
| 74018 |
|
1,190 |
1,155 |
$12K |
| 93976 |
|
57 |
54 |
$12K |
| 86140 |
|
2,860 |
2,780 |
$12K |
| 77073 |
|
466 |
424 |
$12K |
| 86900 |
|
4,825 |
4,664 |
$11K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,541 |
1,419 |
$11K |
| 87147 |
|
815 |
778 |
$11K |
| 80074 |
|
301 |
300 |
$10K |
| J2060 |
Injection, lorazepam, 2 mg |
2,125 |
1,846 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
886 |
860 |
$9K |
| 80076 |
|
1,144 |
1,051 |
$8K |
| C1771 |
Repair device, urinary, incontinence, with sling graft |
12 |
12 |
$8K |
| 82010 |
|
2,115 |
1,979 |
$8K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
2,143 |
1,403 |
$8K |
| 86635 |
|
640 |
466 |
$8K |
| 70498 |
|
425 |
422 |
$8K |
| 86703 |
|
1,010 |
995 |
$7K |
| 80061 |
Lipid panel |
1,274 |
1,105 |
$7K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$7K |
| 86850 |
|
2,383 |
2,322 |
$7K |
| 72072 |
|
394 |
387 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,205 |
1,181 |
$6K |
| 87070 |
|
793 |
771 |
$6K |
| 70491 |
|
75 |
72 |
$5K |
| 88312 |
|
606 |
592 |
$5K |
| 71010 |
|
137 |
84 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,270 |
1,035 |
$5K |
| 87210 |
|
1,591 |
1,558 |
$5K |
| 29075 |
|
304 |
202 |
$5K |
| 20550 |
|
191 |
168 |
$4K |
| C1776 |
Joint device (implantable) |
12 |
12 |
$4K |
| 97750 |
|
537 |
486 |
$4K |
| 0250 |
|
720 |
408 |
$4K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
612 |
483 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
135 |
135 |
$4K |
| 84100 |
|
2,186 |
1,635 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,125 |
973 |
$3K |
| 0324 |
|
44 |
44 |
$3K |
| J1953 |
Injection, levetiracetam, 10 mg |
451 |
343 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,745 |
816 |
$3K |
| 82247 |
|
666 |
465 |
$3K |
| 82746 |
|
215 |
214 |
$3K |
| 84550 |
|
594 |
589 |
$3K |
| L1832 |
Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
12 |
12 |
$2K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
250 |
240 |
$2K |
| 0370 |
|
27 |
15 |
$2K |
| 84466 |
|
223 |
223 |
$2K |
| 45384 |
|
12 |
12 |
$2K |
| 0301 |
|
22 |
15 |
$2K |
| 85651 |
|
1,318 |
1,283 |
$2K |
| 84439 |
|
620 |
607 |
$2K |
| 86592 |
|
1,010 |
843 |
$2K |
| 82140 |
|
542 |
505 |
$2K |
| S0028 |
Injection, famotidine, 20 mg |
1,058 |
1,012 |
$2K |
| 82248 |
|
390 |
270 |
$2K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
57 |
52 |
$2K |
| A9150 |
Non-prescription drugs |
1,417 |
666 |
$2K |
| 20526 |
|
252 |
236 |
$2K |
| 73060 |
|
108 |
107 |
$2K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
67 |
67 |
$2K |
| 73100 |
|
110 |
85 |
$1K |
| 72070 |
|
71 |
70 |
$1K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
521 |
510 |
$1K |
| 87205 |
|
379 |
370 |
$1K |
| 87420 |
|
452 |
410 |
$1K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
28 |
16 |
$1K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
609 |
359 |
$1K |
| 0750 |
|
954 |
938 |
$1K |
| 83540 |
|
227 |
227 |
$1K |
| 84436 |
|
205 |
204 |
$1K |
| 84479 |
|
200 |
200 |
$1K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
546 |
420 |
$1K |
| 85007 |
|
529 |
491 |
$982.66 |
| 72050 |
|
27 |
27 |
$909.29 |
| 73000 |
|
42 |
39 |
$900.69 |
| J7050 |
Infusion, normal saline solution, 250 cc |
368 |
334 |
$848.32 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
165 |
136 |
$845.93 |
| 74022 |
|
109 |
109 |
$845.70 |
| 73552 |
|
40 |
38 |
$845.30 |
| 97161 |
|
76 |
75 |
$818.48 |
| 12001 |
|
26 |
25 |
$773.52 |
| 84425 |
|
75 |
75 |
$768.70 |
| J1630 |
Injection, haloperidol, up to 5 mg |
255 |
232 |
$718.32 |
| J1836 |
Injection, metronidazole, 10 mg |
344 |
196 |
$571.80 |
| 87634 |
|
13 |
12 |
$542.96 |
| 74019 |
|
57 |
56 |
$513.51 |
| 94644 |
|
24 |
24 |
$512.40 |
| Z7500 |
|
26 |
25 |
$511.50 |
| 51701 |
|
25 |
24 |
$454.50 |
| J3360 |
Injection, diazepam, up to 5 mg |
39 |
36 |
$428.84 |
| A9270 |
Non-covered item or service |
878 |
417 |
$421.14 |
| 82272 |
|
251 |
247 |
$420.79 |
| J1940 |
Injection, furosemide, up to 20 mg |
494 |
257 |
$409.77 |
| 73620 |
|
15 |
15 |
$388.53 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
17 |
15 |
$384.73 |
| J0456 |
Injection, azithromycin, 500 mg |
295 |
183 |
$376.66 |
| 72192 |
|
12 |
12 |
$362.05 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
18 |
18 |
$309.60 |
| 96368 |
|
30 |
30 |
$263.08 |
| 82150 |
|
29 |
24 |
$251.79 |
| 73660 |
|
28 |
24 |
$239.49 |
| Q3014 |
Telehealth originating site facility fee |
73 |
73 |
$234.86 |
| 76857 |
|
45 |
45 |
$223.88 |
| 72170 |
|
16 |
13 |
$216.50 |
| 73560 |
|
25 |
25 |
$215.42 |
| 97116 |
|
76 |
65 |
$171.44 |
| 29065 |
|
30 |
12 |
$150.00 |
| 84132 |
|
241 |
192 |
$143.11 |
| J1644 |
Injection, heparin sodium, per 1000 units |
102 |
39 |
$135.81 |
| 84112 |
|
30 |
26 |
$116.02 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
82 |
49 |
$66.19 |
| 0949 |
|
369 |
344 |
$54.67 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
42 |
38 |
$46.81 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
191 |
143 |
$40.48 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
30 |
25 |
$18.34 |
| P9011 |
Blood, split unit |
153 |
142 |
$15.04 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
15 |
12 |
$2.58 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
25 |
25 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
12 |
12 |
$0.00 |
| 72128 |
|
14 |
14 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
19 |
13 |
$0.00 |